Literature DB >> 16937494

Gene expression analysis of primary normal human hepatocytes infected with human hepatitis B virus.

Hyun Mi Ryu1, Sung Gyoo Park, Sung Su Yea, Won Hee Jang, Young-Il Yang, Guhung Jung.   

Abstract

AIM: To find the relationship between hepatitis B virus (HBV) and hepatocytes during the initial state of infection by cDNA microarray.
METHODS: Primary normal human hepatocytes (PNHHs) were isolated and infected with HBV. From the PNHHs, RNA was isolated and inverted into complement DNA (cDNA) with Cy3- or Cy5- labeled dUTP for microarray analysis. The labeled cDNA was hybridized with microarray chip, including 4224 cDNAs. From the image of the microarray, expression profiles were produced and some of them were confirmed by RT-PCR, immunoblot analysis, and NF-kappaB luciferase reporter assay.
RESULTS: From the cDNA microarray, we obtained 98 differentially regulated genes. Of the 98 genes, 53 were up regulated and 45 down regulated. Interestingly, in the up regulated genes, we found the TNF signaling pathway-related genes: LT-alpha, TRAF2, and NIK. By using RT-PCR, we confirmed the up-regulation of these genes in HepG2, Huh7, and Chang liver cells, which were transfected with pHBV1.2x, a plasmid encoding all HBV messages. Moreover, these three genes participated in HBV-mediated NF-kappaB activation.
CONCLUSION: During the initial state of HBV infection, hepatocytes facilitate the activation of NF-kappaB through up regulation of LT-alpha, TRAF2, and NIK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937494      PMCID: PMC4087401          DOI: 10.3748/wjg.v12.i31.4986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.

Authors:  H Y Song; C H Régnier; C J Kirschning; D V Goeddel; M Rothe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Differential gene expression between chronic hepatitis B and C hepatic lesion.

Authors:  M Honda; S Kaneko; H Kawai; Y Shirota; K Kobayashi
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

Review 3.  Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.

Authors:  H Wajant; P Scheurich
Journal:  Int J Biochem Cell Biol       Date:  2001-01       Impact factor: 5.085

4.  Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.

Authors:  Q Wang; R Dziarski; C J Kirschning; M Muzio; D Gupta
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family.

Authors:  W Van Hul; W Wuyts; J Hendrickx; F Speleman; J Wauters; K De Boulle; N Van Roy; P Bossuyt; P J Willems
Journal:  Genomics       Date:  1998-01-15       Impact factor: 5.736

6.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis.

Authors:  M Nakashima; T Toyono; A Akamine; A Joyner
Journal:  Mech Dev       Date:  1999-02       Impact factor: 1.882

7.  Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB.

Authors:  T L VanArsdale; S L VanArsdale; W R Force; B N Walter; G Mosialos; E Kieff; J C Reed; C F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.

Authors:  B H Choi; G T Park; H M Rho
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

10.  Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex.

Authors:  M Kann; B Sodeik; A Vlachou; W H Gerlich; A Helenius
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

View more
  5 in total

Review 1.  Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases.

Authors:  Li Tao; Xiaomeng Ren; Wenhui Zhai; Zheng Chen
Journal:  Molecules       Date:  2022-07-02       Impact factor: 4.927

2.  Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures.

Authors:  Katy M O Goyak; Mary C Johnson; Stephen C Strom; Curtis J Omiecinski
Journal:  Toxicol Appl Pharmacol       Date:  2008-05-10       Impact factor: 4.219

3.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

Review 4.  Noncanonical NF-κB Signaling Pathway in Liver Diseases.

Authors:  Qianhui Chen; Xinyu Lu; Xiaoyong Zhang
Journal:  J Clin Transl Hepatol       Date:  2020-12-21

Review 5.  Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection.

Authors:  Xinyu Lu; Qianhui Chen; Hongyan Liu; Xiaoyong Zhang
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.